About Ahlcon Parenterals (India) Limited
Data last updated:
Ahlcon Parenterals (India) Limited is a public limited company based in New Delhi, Delhi, India, a subsidiary of B. Braun Singapore Pte. Ltd.. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 20 January 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL1992PLC047245. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹200 Cr and a paid-up capital of ₹191.92 Cr. It was formerly known as Gujarat Inject (Rajasthan) Limited. It is led by directors including Aditya Kumar Banerjee (Managing Director) and Navin Hans (Whole-Time Director).
Its last annual general meeting (AGM) was held on 09 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4th Floor Barakhamba Tower 22 Barakhamba Road, Fire Brigade Lane, New Delhi, Delhi, India – 110001.
As per the financials filed for FY 2025, the company reported a revenue of ₹229.53 Cr. For the same year it recorded a net loss of ₹8.21 Cr (net margin -3.6%) and EBITDA of ₹42.77 Cr (EBITDA margin 18.6%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 5% over five years.
The company has about 476 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Ahlcon Parenterals. As per MCA filings, the company has satisfied charges of ₹162.56 Cr on record. Court records list 37 cases involving the company, including 22 filed by the company and 15 filed against it; 10 cases are pending. The company has 42 deals on record (41 market trades, 1 acquisition); the latest was in July 2012. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 5 smaller; the largest is Emil Pharmaceutical Industries Private Limited with revenue of ₹232.55 Cr. The company has 18 MSME Form 1 returns on record between 2019 and 2024, listing 993 overdue payments to 129 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ahlconindia.com.
Company details
CIN history
Ahlcon Parenterals (India) has one previous CIN (Corporate Identification Number): L24239DL1992PLC047245. The current CIN is U24239DL1992PLC047245, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239DL1992PLC047245 | Current |
| L24239DL1992PLC047245 | Previous |
Contact details
Ahlcon Parenterals (India) Limited's registered office is in New Delhi, Delhi. Its website is ahlconindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address4th Floor Barakhamba Tower 22 Barakhamba Road, Fire Brigade Lane, New Delhi, Delhi, India – 110001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ahlcon Parenterals (India) Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Ahlcon Parenterals (India) operates one associated brand: Ahlcon Parenterals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Large and small volume parenteral formulations are manufactured for markets. | ahlconindia.com |
Business activity
The main business activity of Ahlcon Parenterals (India) is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ahlcon Parenterals (India) Limited, buy the company report.
Financials of Ahlcon Parenterals (India) Limited
FY 2025 filings availableAhlcon Parenterals (India) Limited reported revenue of ₹229.53 Cr for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹42.77 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹8.21 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 18.6% | ||||
| Net Profit Margin | -3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ahlcon Parenterals (India) Limited, buy the company report.
Board of directors and KMP of Ahlcon Parenterals (India) Limited
Ahlcon Parenterals (India) Limited currently reports 5 directors and 1 key managerial person. 26 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Mathur Also directs: Apex Ecotech Limited | Director | 02 Jul 2025 | 1 Years 3 Months | Current |
| Eva Fatima Maegerlein | Director | 31 Oct 2022 | 3 Years 11 Months | Current |
| Navin Hans | Whole-Time Director | 28 Apr 2023 | 3 Years 6 Months | Current |
| Vinod Kumar Bajaj | Director | 02 Jul 2025 | 1 Years 3 Months | Current |
| Rajesh Garg | Cfo | 12 Aug 2024 | 2 Years 2 Months | Current |
| Aditya Kumar Banerjee Also directs: B.Braun Medical (India) Private Limited, Oyster Medisafe Private Limited, Ag Infrastructure Private Limited and 1 more | Managing Director | 01 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Ahlcon Parenterals (India) Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Emil Pharmaceutical Industries Private Limited | ₹232.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Axa Parenterals Limited | ₹231.46 Cr (FY 2025) | 6.0% | Delhi, India | |||
| Dosch Pharmaceuticals Private Limited | ₹229.86 Cr (FY 2025) | 3.0% | Mumbai, Maharashtra, India | |||
| Ahlcon Parenterals (India) Limitedthis company | ₹229.53 Cr (FY 2025) | -₹8.21 Cr | -3.6% | 476 | New Delhi, Delhi, India | |
| Medopharm Private Limited | ₹229.32 Cr (FY 2025) | -9.0% | Chennai, Tamil Nadu, India | |||
| Hindustan Laboratories Limited | ₹227.37 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Salvi Chemical Industries Limited | ₹225.29 Cr (FY 2025) | 47.0% | Mumbai, Maharashtra, India | |||
| Aura Pharmaceuticals Private Limited | ₹223.55 Cr (FY 2025) | 10.0% | Mumbai, Maharashtra, India | |||
| Venus Biosciences Private Limited | ₹222.32 Cr (FY 2016) | 48.0% | Solan, Himachal Pradesh, India |
To see the full peer comparison of Ahlcon Parenterals (India) Limited, buy the company report.
Auditor
Ahlcon Parenterals (India) Limited is audited by Price Waterhouse Cha r t e r ed Accountants LLP for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Cha r t e r ed Accountants LLP | FY 2021 | 012754N/ N500016 |
Shareholding
The shareholding of Ahlcon Parenterals (India) Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ahlcon Parenterals (India) Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 25 Mar 2010 | 10214301 | Punjab & Sind Bank | ₹13 Cr | Satisfied | |
| 25 Mar 2010 | 10214300 | Punjab & Sind Bank | ₹21.11 Cr | Satisfied | |
| 25 Mar 2010 | 10214298 | Punjab & Sind Bank | ₹4 Cr | Satisfied | |
| 25 Mar 2010 | 10214302 | Punjab & Sind Bank | ₹35.85 Cr | Satisfied | |
| 22 Oct 2005 | 80028969 | Syndicate Bank | ₹37 Cr | Satisfied |
To see the full charge records of Ahlcon Parenterals (India) Limited, buy the company report.
Total charge records: 8 View all charges
Deals & funding
Ahlcon Parenterals (India) Limited has 42 deals on record (41 market trades, 1 acquisition); the latest was in July 2012.
Deals on record (5 of 42)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jul 2012 | Market trade | ₹2.05 Cr | Seller: Globe Capital Market Limited |
| Jul 2012 | Market trade | ₹2.24 Cr | Seller: Globe Capital Market Limited |
| May 2012 | Market trade | ₹2.21 Cr | Seller: Rajasthan Global Securities Private Limited |
| May 2012 | Market trade | ₹3 Cr | Buyer: Globe Capital Market Limited Seller: Rajasthan Global Securities Private Limited |
| May 2012 | Market trade | ₹6.73 Cr | Buyer: Sewastuti Finance Private Limited. Seller: an individual |
To see the full deal history of Ahlcon Parenterals (India) Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Ahlcon Parenterals (India) Limited has 37 court cases on record: 22 filed by Ahlcon Parenterals (India), 15 filed against it. 10 cases are pending and 27 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 24 | 10 | 8 |
| District courts | 11 | 4 | 2 |
| Supreme Court | 2 | 1 | 0 |
Cases on record (5 of 37)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed by the company against Scan Biotech Ltd | Pending |
| High Court of Delhi | Court case (O.M.P. (COMM)) | Filed against the company by Scan Biotech Limited | Pending |
| High Court, Rajasthan | Appeal | Filed against the company by M/S Lifestar Pharma Pvt Ltd | Pending |
| District court, Faridabad, Haryana | Court case (C S) | Filed against the company by M/S Hi-Pack and Fill Machines Pvt. Ltd. | Disposed |
| High Court of Delhi | Court case (O.M.P. (COMM)) | Filed by the company against Scan Biotech Ltd. | Disposed |
To see the full case history of Ahlcon Parenterals (India) Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Ahlcon Parenterals (India) Limited has 18 MSME Form 1 returns on record between 2019 and 2024, listing 993 overdue payments to 129 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 129)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Rommelag Engineering India Private Limited | |||
| Crown Art Printers | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Ahlcon Parenterals (India) Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Ahlcon Parenterals (India) Limited has a workforce of 476 employees on its EPFO records as of Apr 01, 2024, across 1 active EPFO establishment.
GST
Ahlcon Parenterals (India) has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Ahlcon Parenterals (India) Limited, buy the company report.
Recent activity
Ahlcon Parenterals (India) Limited has 31 board changes on record since 2007: 6 appointments and 25 cessations. The latest: Rajiv Mathur was appointed as Director on 02 Jul 2025.
44 earlier events are in the company report.
Frequently asked questions
Ahlcon Parenterals (India) is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 20 January 1992 (34+ years old) and is registered under CIN U24239DL1992PLC047245.
Ahlcon Parenterals (India) has 6 current directors and KMP:
- Aditya Kumar Banerjee - Managing Director
- Navin Hans - Whole-Time Director
- Rajiv Mathur - Director
- Eva Fatima Maegerlein - Director
- Vinod Kumar Bajaj - Director
- Rajesh Garg - Cfo
The latest financial statements of Ahlcon Parenterals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 09 September 2025. Year-wise statements from 2015 are in the company report.
No. Ahlcon Parenterals (India) has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Ahlcon Parenterals (India) is U24239DL1992PLC047245. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ahlcon Parenterals (India) has 37 court cases on record: 22 filed by the company and 15 filed against it. 10 are pending. Most are in the high courts.
Ahlcon Parenterals (India) was incorporated on 20 January 1992, making it 34+ years old. It is registered with the Registrar of Companies, Delhi.
Ahlcon Parenterals (India) has 42 deals on record (41 market trades, 1 acquisition); the latest was in July 2012.
The peers of Ahlcon Parenterals (India) by revenue are Emil Pharmaceutical Industries Private Limited, Axa Parenterals Limited, Dosch Pharmaceuticals Private Limited, Medopharm Private Limited, Hindustan Laboratories Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rajiv Mathur was appointed as Director on 02 Jul 2025. Vinod Kumar Bajaj was appointed as Director on 02 Jul 2025. Rajiv Mathur ceased to be Additional Director on 12 Sep 2024. Ahlcon Parenterals (India) has 31 board changes on record in total.
Ahlcon Parenterals (India) has 18 MSME Form 1 returns on record between 2019 and 2024, listing 993 overdue payments to 129 micro and small suppliers. The latest return was filed on 30 Apr 2024.
Ahlcon Parenterals (India) can be reached through the website ahlconindia.com. Its registered office is in New Delhi, Delhi, India.